The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AGITG SPAR: A randomized, placebo-controlled, phase II trial of simvastatin in addition to neoadjuvant chemotherapy and radiation for rectal cancer.
 
Michael Jameson
Research Funding - Bristol-Myers Squibb (Inst); HUYA Bioscience International (Inst); Incyte (Inst); MSD Oncology (Inst); Pfizer (Inst); Sabinsa Corporation (Inst)
 
Kirsten Gormly
No Relationships to Disclose
 
David Espinoza
No Relationships to Disclose
 
Michael Arendse
No Relationships to Disclose
 
Derrick Siu
No Relationships to Disclose
 
Ailsa Langford
No Relationships to Disclose
 
Mark Jeffery
No Relationships to Disclose
 
Christos Karapetis
Honoraria - Eisai; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Lilly; Merck Serono; Pierre Fabre; Roche; Takeda
 
Swetha Sridharan
Travel, Accommodations, Expenses - Pfizer (Inst)
 
Matthew Burge
Stock and Other Ownership Interests - coclear; CSL Limited; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Anne O'Donnell
No Relationships to Disclose
 
Andrew Oar
Employment - Icon Cancer Care
Stock and Other Ownership Interests - Icon Cancer Care; Tutelix Pty Ltd
 
Angela Mweempwa
No Relationships to Disclose
 
James Armstrong
No Relationships to Disclose
 
Timothy Price
Consulting or Advisory Role - Amgen; Astrazeneca (Inst); BMS (Inst); Merck; Takeda
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
Samuel Ngan
No Relationships to Disclose
 
Frank Frizelle
No Relationships to Disclose
 
Andrew Stevenson
Honoraria - Cook Biotech
Research Funding - Intuitive Surgical
Travel, Accommodations, Expenses - Cook Biotech; Stryker
 
Katrin Sjoquist
Honoraria - Astellas Pharma; Bayer (Inst); BMS; Glenmark (Inst); Lisata (Inst); MSD; Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
Stephen Ackland
Consulting or Advisory Role - Bod australia
Research Funding - FivePhusion (Inst)
Other Relationship - Servier/Pfizer
(OPTIONAL) Uncompensated Relationships - fivepHusion